AIC
CLSD

Ameritas Investment Company’s Clearside Biomedical CLSD Stock Holding History

Ameritas Investment Company’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$365K Buy
4,054
+667
+20% +$58.9K 0.02% 499
2021
Q2 		$247K Buy
+3,387
New +$157K 0.01% 624

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's CLSD Position: Q3 2021 in Review

Ameritas Investment Company increased its Clearside Biomedical (CLSD) stake by 20% in Q3 2021, buying an estimated $58.9K and bringing the position to 4,054 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #499.

Ameritas Investment Company first reported a position in CLSD in Q2 2021 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold CLSD as of Q3 2021.

  • Ameritas Investment Company held 4,054 shares of Clearside Biomedical worth $365K as of Q3 2021.
  • Ameritas Investment Company bought 667 Clearside Biomedical shares in Q3 2021, an estimated $58.9K.
  • Clearside Biomedical made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #499 holding.
  • Ameritas Investment Company first reported a position in Clearside Biomedical in Q2 2021 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.